PRESTAPHARM : revenue, balance sheet and financial ratios

PRESTAPHARM is a French company founded 8 years ago, specialized in the sector Location et location-bail d'autres biens personnels et domestiques. Based in PEYROLLES-EN-PROVENCE (13860), this company of category PME shows in 2022 a revenue of 138 k€. Find below the complete financial statements, solvency ratios, working capital requirements and sector comparison.

Data updated on 2026-05-09

Sources : INPI & INSEE SIRENE - Processing : Ministry of Economy

Financial history - PRESTAPHARM (SIREN 834120990)
Indicator 2023 2022 2021 2020
Revenue N/C 138 108 € 133 583 € 81 022 €
Net income 0 € -9 627 € 11 857 € 10 628 €
EBITDA N/C 5 098 € 18 762 € 14 534 €
Net margin N/C -7.0% 8.9% 13.1%

Revenue and income statement

In 2023, PRESTAPHARM records a net loss of 0 €. This deficit will reduce equity on the balance sheet.

Loading income statement...

Chart evolution

Show :

Assets

Loading data...

Liabilities

Loading data...

Solvency and debt ratios

The debt ratio (= Financial debt / Equity x 100) stands at 42%. Debt remains under control: the company retains capacity to raise new debt if needed. Financial autonomy (= Equity / Total assets x 100) reaches 17%. Low autonomy: the company heavily depends on external financing (banks, suppliers).

Debt ratio (2023) ?
Debt ratio
Definition
Measures the proportion of debt to equity.
Formula
(Financial debt / Equity) x 100
Interpretation
< 50% : Low
50-100% : Moderate
> 100% : High

42.312%

Financial autonomy (2023) ?
Financial autonomy
Definition
Share of equity in the company's total financing.
Formula
(Equity / Total assets) x 100
Interpretation
> 30% : Good autonomy
20-30% : Average
< 20% : Low

17.474%

Asset age ratio (2023) ?
Asset age ratio
Definition
Measures the degree of wear of tangible assets.
Formula
Accumulated depreciation / Gross fixed assets x 100
Interpretation
< 50% : Recent assets
50-70% : Normal wear
> 70% : Aging assets

13.5%

Solvency indicators evolution
PRESTAPHARM

Sector positioning

Debt ratio
42.31 2023
2021
2022
2023
Q1: 0.0
Med: 10.94
Q3: 83.08
Average

In 2023, the debt ratio of PRESTAPHARM (42.31) ranks above the median of the sector. This ratio measures the weight of debt relative to equity. A reduction effort could improve financial strength.

Financial autonomy
17.47% 2023
2021
2022
2023
Q1: 5.32%
Med: 32.76%
Q3: 61.66%
Average -5 pts over 3 years

In 2023, the financial autonomy of PRESTAPHARM (17.5%) ranks below the median of the sector. This ratio represents the share of equity in total financing. An improvement would strengthen the competitive position.

Repayment capacity
-10.03 years 2022
2021
2022
Q1: 0.0 years
Med: 0.03 years
Q3: 1.43 years
Excellent -45 pts over 2 years

In 2022, the repayment capacity of PRESTAPHARM (-10.03) ranks in the bottom 25% of the sector, which is positive. This ratio indicates the number of years needed to repay debt with cash flow. A short capacity reflects controlled debt and good cash generation.

Liquidity ratios

The liquidity ratio (= Current assets / Current liabilities) stands at 228.63. Concretely, the company has €2 of liquid assets for every €1 of short-term debt: no cash risk within 12 months.

Liquidity ratio (2023) ?
Liquidity ratio
Definition
Ability to meet short-term debts with current assets.
Formula
Current assets / Current liabilities
Interpretation
> 1.5 : Very good
1-1.5 : Fair
< 1 : Liquidity risk

228.627

Liquidity indicators evolution
PRESTAPHARM

Sector positioning

Liquidity ratio
228.63 2023
2021
2022
2023
Q1: 106.21
Med: 176.19
Q3: 306.8
Good -15 pts over 3 years

In 2023, the liquidity ratio of PRESTAPHARM (228.63) ranks above the median of the sector. This ratio measures the ability to cover short-term debt with current assets. This comfortable position offers an appreciable safety margin.

Interest coverage
9.02x 2022
2021
2022
Q1: 0.0x
Med: 0.04x
Q3: 1.23x
Excellent

In 2022, the interest coverage of PRESTAPHARM (9.0x) ranks in the top 25% of the sector. This ratio indicates how many times operating income covers interest expenses. High coverage means financial charges weigh little on profitability.

Working capital requirement (WCR) and payment terms

Working capital requirement (WCR) measures the cash timing gap between customer collections and supplier/inventory payments. Average customer payment term: 185 days (formula: Customer receivables / Revenue incl. VAT x 360). Supplier term: 311 days. Excellent situation: suppliers finance 126 days of the operating cycle (retail model).

Operating WCR (2023) ?
Operating WCR
Definition
Financing requirement generated by the operating cycle (inventory + receivables - trade payables).
Formula
Inventory + Customer receivables - Trade payables
Interpretation
Negative = cash released
Positive = financing needed

0 €

Customer credit (2023) ?
Customer credit (days)
Definition
Average payment term granted to customers.
Formula
(Customer receivables / Revenue incl. VAT) x 360
Interpretation
< 45j : Good
45-60j : Average
> 60j : Long

185 j

Supplier credit (2023) ?
Supplier credit (days)
Definition
Average payment term obtained from suppliers.
Formula
(Trade payables / Purchases incl. VAT) x 360
Interpretation
The longer the term, the better for cash flow

311 j

Inventory turnover (2023) ?
Inventory turnover (days)
Definition
Average storage duration for goods or materials.
Formula
(Inventory / Cost of goods) x 360
Interpretation
The lower the ratio, the faster the turnover

0 j

WCR and payment terms evolution
PRESTAPHARM

Positioning of PRESTAPHARM in its sector

Comparison with sector Location et location-bail d'autres biens personnels et domestiques

Similar companies (Location et location-bail d'autres biens personnels et domestiques)

Compare PRESTAPHARM with other companies in the same sector:

Voir toutes les statistiques du secteur Location et location-bail d'autres biens personnels et domestiques

Frequently asked questions about PRESTAPHARM

What is the revenue of PRESTAPHARM ?

The revenue of PRESTAPHARM in 2022 is 138 k€.

Is PRESTAPHARM profitable?

PRESTAPHARM recorded a net loss in 2022.

Where is the headquarters of PRESTAPHARM ?

The headquarters of PRESTAPHARM is located in PEYROLLES-EN-PROVENCE (13860), in the department Bouches-du-Rhone.

Where to find the tax return of PRESTAPHARM ?

The tax return of PRESTAPHARM is available on this page. Click on a year in the 'Data by year' section to view the account details (assets, liabilities, income statement). Data comes from INPI (National Institute of Industrial Property).

In which sector does PRESTAPHARM operate?

PRESTAPHARM operates in the sector Location et location-bail d'autres biens personnels et domestiques (NAF code 77.29Z). See the 'Sector positioning' section above to compare the company with its competitors.